Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ).
ASKA Pharmaceutical Holdings Co., Ltd. reported its consolidated financial results for the first quarter of FY2025, showing an 18.2% increase in net sales compared to the previous year. However, the company experienced declines in operating profit, ordinary profit, and profit attributable to owners of the parent, indicating challenges in maintaining profitability. Despite these challenges, ASKA’s financial position remains stable with a slight increase in total assets. The company maintains its forecast for the full fiscal year, expecting significant growth in operating profit and ordinary profit, which suggests a positive outlook for stakeholders.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is known for its commitment to advancing healthcare solutions.
Average Trading Volume: 39,087
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen65.55B
For a thorough assessment of 4886 stock, go to TipRanks’ Stock Analysis page.